4//SEC Filing
Mohan Pankaj 4
Accession 0001493152-23-005473
CIK 0001106838other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:50 PM ET
Size
9.2 KB
Accession
0001493152-23-005473
Insider Transaction Report
Form 4
Mohan Pankaj
DirectorChairman, President and CEO
Transactions
- Award
Common Stock
2023-01-07+73,561→ 121,731 total - Disposition to Issuer
Common Stock
2023-01-07−73,561→ 48,170 total
Holdings
- 570(indirect: By Children)
Common Stock
- 66,478(indirect: By Mohan Family Office)
Common Stock
Footnotes (4)
- [F1]On December 14, 2022, the Reporting Person was granted 73,561 restricted stock units to be settled in shares of common stock, par value $0.0001. On January 7, 2023, the 73,561 restricted stock units granted to the Reporting Person were rescinded and canceled. On the same day, the Reporting Person was granted a restricted stock award of 73,561 shares of common stock. The shares in connection with the restricted stock award become fully vested on January 1, 2024, provided the Reporting Person remains in continuous service through such date.
- [F2]A Form 4 that was filed by the Reporting Person on December 22, 2022, reported a transaction on December 14, 2022, that incorrectly referred to the amount of restricted stock units granted as 74,205. The correct number was 73,561 restricted stock units. In addition, the Form 4 incorrectly included amounts in Column 5 of Table I that did not reflect a 14:1 reverse stock split of the Issuer's common stock, effective September 16, 2022.
- [F3]Includes unvested restricted stock units.
- [F4]Reporting Person jointly exercises dispositive and voting power over the securities owned by the Mohan Family Office.
Documents
Issuer
Sonnet BioTherapeutics Holdings, Inc.
CIK 0001106838
Entity typeother
Related Parties
1- filerCIK 0001664386
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:50 PM ET
- Size
- 9.2 KB